The firm will begin marketing the navigation and imaging system in early 2011. 1 September 10 11:44, Hillel Koren Mazor Surgical Technologies Ltd. (TASE:MZOR) has obtained US Food and Drug Administration (FDA) approval for the company’s combined spinal surgical system comprising the SpineAssist miniature robotic navigation system and C-Insight 3D imaging system.
Mazor directly handles sales of its products in Germany through its sales team. Mazor Surgical Technologies Ltd. (TASE:MZOR) today reported the first sales of its GO-LIF spine implants in Germany. The company already has sales of the implants in Russia. Mazor directly handles sales of its products in Germany through its sales team, while in [...]
BY LAUREN UZDIENSKI, OCTOBER 26, 2009 Israel-based Mazor Surgical Technologies has raised NIS 48 million ($13 million) in shares and warrants in a public offering that closed this week. Total proceeds include funding from an institutional offering to Yorkville Advisors LLC, which was announced last week and made up to $15 million in stock available [...]
Enter your email address below to receive updates each time we publish new content.
Is it time to update your social media policy?
By Karen M. Cheung With the Federation of State Medical Boards (FSMB) this week releasing new guidelines for physicians on this particular topic, FierceHealthcare is dedicating this week’s commentary to a round-up of the best practices to help hospitals draw on other policies to see what fits at their institutions.
How to maintain physician professionalism in social media
by MARK RYAN, MD Art is not a mirror held up to reality but a hammer with which to shape it. – Bertolt Brecht
The ethics of social media use for the medical profession
by Emily Lu At the end of the day, I do not see social media as an end to itself.
